Phase I trial of Acura Pharmaceuticals' abuse-resistant hydromorphone (LTX-04)

Trial Profile

Phase I trial of Acura Pharmaceuticals' abuse-resistant hydromorphone (LTX-04)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Hydromorphone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Acura Pharmaceuticals
  • Most Recent Events

    • 14 Dec 2016 Results published in the Acura Pharmaceuticals Media Release.
    • 11 Jul 2016 According to an Acura Pharmaceuticals media release. the company will present detailed analysis of data from this trial in a conference call and webcast on July 14, 2016.
    • 08 Jun 2016 Topline results from cohort 2 of this trial published in an Acura Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top